Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180


Very late stent thrombosis caused by neoatherosclerotic plaque rupture.

Hougaard M, Thayssen P, Hansen HS, Jensen LO.

EuroIntervention. 2015 Apr 22;10(12):e1-3. doi: 10.4244/EIJV10I12A251. No abstract available.


10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).

Maeng M, Baranauskas A, Christiansen EH, Kaltoft A, Holm NR, Krusell LR, Ravkilde J, Tilsted HH, Thayssen P, Jensen LO.

Catheter Cardiovasc Interv. 2015 Jan 30. doi: 10.1002/ccd.25875. [Epub ahead of print]


Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.

Raungaard B, Jensen LO, Tilsted HH, Christiansen EH, Maeng M, Terkelsen CJ, Krusell LR, Kaltoft A, Kristensen SD, Bøtker HE, Thuesen L, Aarøe J, Jensen SE, Villadsen AB, Thayssen P, Veien KT, Hansen KN, Junker A, Madsen M, Ravkilde J, Lassen JF; Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT).

Lancet. 2015 Apr 18;385(9977):1527-35. doi: 10.1016/S0140-6736(14)61794-3. Epub 2015 Jan 16.


Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy).

Olesen KK, Tilsted HH, Jensen LO, Kaltoft A, Krusell LR, Ravkilde J, Christiansen EH, Madsen M, Thayssen P, Sørensen HT, Lassen JF, Maeng M.

Am J Cardiol. 2015 Feb 1;115(3):298-302. doi: 10.1016/j.amjcard.2014.10.038. Epub 2014 Nov 11.


Large coronary intramural hematomas: a case series and focused literature review.

Antonsen L, Thayssen P, Jensen LO.

Cardiovasc Revasc Med. 2015 Mar;16(2):116-123. doi: 10.1016/j.carrev.2014.10.009. Epub 2014 Oct 31. Review.


Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.

Kristensen SL, Galløe AM, Thuesen L, Kelbæk H, Thayssen P, Havndrup O, Hansen PR, Bligaard N, Saunamäki K, Junker A, Aarøe J, Abildgaard U, Jeppesen JL.

PLoS One. 2014 Nov 19;9(11):e113399. doi: 10.1371/journal.pone.0113399. eCollection 2014.


Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.

Thim T, Johansen MB, Chisholm GE, Schmidt M, Kaltoft A, Sørensen HT, Thuesen L, Kristensen SD, Bøtker HE, Krusell LR, Lassen JF, Thayssen P, Jensen LO, Tilsted HH, Maeng M.

BMC Cardiovasc Disord. 2014 Aug 13;14:100. doi: 10.1186/1471-2261-14-100.


Intracoronary injection of CD34-cells in chronic ischemic heart failure: 7 years follow-up of the DanCell study.

Hansen M, Nyby S, Eifer Møller J, Videbæk L, Kassem M, Barington T, Thayssen P, Diederichsen AC.

Cardiology. 2014;129(2):69-74. doi: 10.1159/000363133. Epub 2014 Aug 12.


Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.

Jensen LO, Thayssen P, Maeng M, Christiansen EH, Ravkilde J, Hansen KN, Kaltoft A, Tilsted HH, Madsen M, Lassen JF; Scandinavian Organization for Randomized Trials With Clinical Outcome SORT OUT IV Investigators.

JACC Cardiovasc Interv. 2014 Aug;7(8):840-8. doi: 10.1016/j.jcin.2014.02.014. Epub 2014 Jul 30.


Peri-stent contrast staining, major evaginations and severe malapposition after biolimus-eluting stent implantation: a case report based on coronary optical frequency domain imaging.

Antonsen L, Thayssen P, Jensen LO.

Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):424-7. doi: 10.1016/j.carrev.2014.04.006. Epub 2014 Apr 26.


Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.

Thayssen P, Lassen JF, Jensen SE, Hansen KN, Hansen HS, Christiansen EH, Junker A, Ravkilde J, Thuesen L, Veien KT, Jensen LO.

Circ Cardiovasc Interv. 2014 Apr;7(2):216-24. doi: 10.1161/CIRCINTERVENTIONS.113.000653. Epub 2014 Apr 8.


Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Maeng M, Tilsted HH, Jensen LO, Krusell LR, Kaltoft A, Kelbæk H, Villadsen AB, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Thuesen L, Madsen M, Thayssen P, Sørensen HT, Lassen JF.

Lancet. 2014 Jun 14;383(9934):2047-56. doi: 10.1016/S0140-6736(14)60405-0. Epub 2014 Mar 14.


Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents.

Bligaard N, Thuesen L, Saunamäki K, Thayssen P, Aarøe J, Hansen PR, Lassen JF, Stephansen G, Jeppesen JL, Galløe AM; SORT OUT II investigators.

Scand Cardiovasc J. 2014 Jun;48(3):148-55. doi: 10.3109/14017431.2014.883461. Epub 2014 Feb 26.


Impact of renal insufficiency on mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Sabroe JE, Thayssen P, Antonsen L, Hougaard M, Hansen KN, Jensen LO.

BMC Cardiovasc Disord. 2014 Feb 7;14:15. doi: 10.1186/1471-2261-14-15.


Immediate mobilization after coronary angiography or percutaneous coronary intervention following hemostasis with the AngioSeal vascular closure device (the MOBS study).

Larsen EN, Hansen CB, Thayssen P, Jensen LO.

Eur J Cardiovasc Nurs. 2014 Oct;13(5):466-72. doi: 10.1177/1474515113516702. Epub 2013 Dec 13.


Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.

Hougaard M, Thayssen P, Kaltoft A, Tilsted HH, Maeng M, Lassen JF, Thuesen L, Okkels Jensen L.

Catheter Cardiovasc Interv. 2014 Jun 1;83(7):1035-42. doi: 10.1002/ccd.25279. Epub 2013 Dec 5.


Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.

Kervinen K, Niemelä M, Romppanen H, Erglis A, Kumsars I, Maeng M, Holm NR, Lassen JF, Gunnes P, Stavnes S, Jensen JS, Galløe A, Narbute I, Sondore D, Christiansen EH, Ravkilde J, Steigen TK, Mannsverk J, Thayssen P, Hansen KN, Helqvist S, Vikman S, Wiseth R, Aarøe J, Jokelainen J, Thuesen L; Nordic PCI Study Group.

JACC Cardiovasc Interv. 2013 Nov;6(11):1160-5. doi: 10.1016/j.jcin.2013.06.009.


Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology.

Thuesen L, Jensen LO, Tilsted HH, Mæng M, Terkelsen C, Thayssen P, Ravkilde J, Christiansen EH, Bøtker HE, Madsen M, Lassen JF.

Clin Epidemiol. 2013 Sep 19;5:357-61. doi: 10.2147/CLEP.S44651. eCollection 2013.


Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.

Antonsen L, Maeng M, Thayssen P, Christiansen EH, Hansen KN, Kaltoft A, Hansen HS, Thuesen L, Lassen JF, Jensen LO.

Catheter Cardiovasc Interv. 2014 May 1;83(6):864-72. doi: 10.1002/ccd.25180. Epub 2013 Sep 30.


Hybrid CT angiography and quantitative 15O-water PET for assessment of coronary artery disease: comparison with quantitative coronary angiography.

Thomassen A, Petersen H, Diederichsen AC, Mickley H, Jensen LO, Johansen A, Gerke O, Braad PE, Thayssen P, Høilund-Carlsen MM, Vach W, Knuuti J, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1894-904. doi: 10.1007/s00259-013-2519-3. Epub 2013 Aug 28.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk